Rwanda is fighting its first outbreak of the “highly virulent” Marburg virus which was first reported in late September.
As of Thursday, 11 people were reported to have died of the virus in Rwanda. The health minister announced the country will begin clinical trials of experimental vaccines and treatments
What is the Marburg virus?
Marburg is from the same family as Ebola, namely the Filoviridae family (filovirus) of viruses. It has been described as more severe than Ebola.
It causes a haemorrhagic fever, which is a type of fever that can damage the walls of blood vessels, according to information from the Mayo Clinic. Other diseases which produce this type of fever include dengue and yellow fever.
According to the Mayo Clinic, a haemorrhagic fever causes internal bleeding, which can be fatal
The virus was first identified in 1967 in a town in Germany called Marburg, from which it gained its name. Simultaneously, it was identified in Belgrade, Serbia.
The World Health Organization (WHO) estimates the case fatality rate to be between 24 and 88 percent. On average, about half of all those who contract the virus die from it
After a person is exposed to the virus, it can take between two and 21 days for symptoms to show, according to the WHO.
“Fatal cases usually have some form of bleeding, often from multiple areas,” the website says, adding that the onset of bleeding can occur within five to seven days.
Bleeding in vomit or faeces is often accompanied by bleeding from the nose, gums and vagina, WHO’s website says.
In severe cases, death can occur eight or nine days after symptoms start to show.
“Those with weakened immune systems are more susceptible to severe illness and death from this virus,” infectious disease expert Amira Roess told Al Jazeera. Roess is a global health and epidemiology professor at George Mason University’s College of Public Health
What are the symptoms?
According to the Centers for Disease Control and Prevention (CDC), Marburg virus symptoms include fever, headache, muscle and joint pain, fatigue, appetite loss, bleeding and gastrointestinal symptoms.
How does the Marburg virus spread?
Some people have contracted the Marburg virus after coming in contact with Rousettus bats, a type of fruit bat found in mines and caves, that carry the virus.
The source of the Rwanda outbreak remains unclear, however.
Once an individual contracts the virus, they can transmit it to others through direct contact with bodily fluids via broken skin or mucous membranes. The WHO website says even surfaces contaminated with bodily fluids, such as bedsheets or clothing, can spread the virus.
According to information from the CDC, the virus is not airborne
What is the situation in Rwanda?
There are currently 36 confirmed cases of Marburg in Rwanda, with 25 people being cared for in isolation, according to the government’s latest update.
According to the WHO, on September 30 when there were 26 confirmed cases, 70 percent of the cases were in healthcare workers in two of the country’s healthcare facilities, which were not named.
It’s not uncommon to see outbreaks in healthcare facilities, especially in low-resourced healthcare facilities that may not have sufficient infection control,” Roess said.
Where has the Marburg virus spread?
On September 27, Rwanda’s Ministry of Health confirmed the latest outbreak of the Marburg virus.
The current outbreak has only been reported in Rwanda so far.
There were fears that the virus had reached Germany when two passengers on a train from Frankfurt to Hamburg contacted doctors, fearing they had the virus.
Rwanda’s Minister of Health Sabin Nsanzimana, announced on Thursday that the country is racing to develop a vaccine.
The WHO said some candidate vaccines are being manufactured. These include vaccines developed by the International AIDS Vaccine Initiative (IAVI) and by the Sabin Vaccine Institute which said it is collaborating with the Rwandan government.
The team at Oxford University which formulated the AstraZeneca vaccine for COVID-19 started a trial of its Marburg vaccine candidate this summer in the United Kingdom, employing similar technology to the COVID vaccine.